[Methylxanthines: a new look at the mechanism of their therapeutic action].
Kulinskiĭ
V I
VI
D000241:Adenosine / Q000037:antagonists & inhibitors; D000818:Animals; D000242:Cyclic AMP / Q000037:antagonists & inhibitors; D006801:Humans; D010726:Phosphodiesterase Inhibitors; D018160:Receptors, Cytoplasmic and Nuclear; D011983:Receptors, Purinergic / Q000187:drug effects; D014018:Tissue Distribution; D014970:Xanthines / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
C037688:ADP-ATP carrier receptor; D010726:Phosphodiesterase Inhibitors; D018160:Receptors, Cytoplasmic and Nuclear; D011983:Receptors, Purinergic; D014970:Xanthines; C008514:methylxanthine; D000242:Cyclic AMP; D000241:Adenosine
Metilksantiny: novyĭ vzgliad na mekhanizm terapevticheskogo deĭstviia.